Matthew Maxwell Laughon MD, MPH

Matthew Maxwell Laughon is a Professor at the University of North Carolina. Dr. Laughon is a physician and researcher who specializes in neonatal and perinatal medicine. His research interests include neonatal epidemiology, neonatal clinical pharmacology trials (phase I, II, and III), and neonatal lung disease-particularly bronchopulmonary dysplasia (BPD). His research work integrates the clinical efforts of neonatologists and pharmacologists from academic healthcare institutions across the US to determine the efficacy of medications in pediatric populations.

Dr. Laughon’s future research plans include continuing investigation into medications used to treat common health problems associated with premature birth, including bronchopulmonary dysplasia, pulmonary arterial hypertension, and patent ductus arteriosus. He completed his Doctor of Medicine at the University of Virginia.